Reprint

Marine Glycobiology, Glycomics and Lectins

Edited by
November 2019
176 pages
  • ISBN978-3-03921-820-2 (Paperback)
  • ISBN978-3-03921-821-9 (PDF)

This book is a reprint of the Special Issue Marine Glycobiology, Glycomics and Lectins that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

Glycans (carbohydrate chains) of marine creatures are rich and diverse in polysaccharides, glycoproteins, and glycolipids. The chains that are metabolized by glycan-related enzymes (glycosyltransferases and glycosidases) are recognized by glycan-binding proteins (lectins) which regulate cellular processes such as growth, differentiation, and death. Marine glycomics that involves the genome and transcriptome accelerates our understanding of the evolution of glycans, glycan-related enzymes, and lectins.

From 2017 to 2019, the Special Issue “Marine Glycobiology, Glycomics and Lectins” of the journal Marine Drugs published scientific articles and reviews, on the background of “glycobiology”—that is, glycan-based biosciences. The aim was to promote the discovery of novel biomolecules that contribute to drug development and clinical studies. This has great potential for establishing connections between the fields of both human health and marine life sciences.

This book contains 11 scientific papers representing current topics in comprehensive glycosciences related to therapeutic agents from marine natural products, as outlined.

Format
  • Paperback
License
© 2020 by the authors; CC BY license
Keywords
HddSBL; oncolytic vaccinia virus; glioblastoma; adverse effects; TTL; oncolytic vaccinia virus; viral replication; ERK; β-galactosidase; recombinant; thermostable; transglycosylation; galactooligosaccharides; Marinomonas; Pattalus mollis; fucosylated glycosaminoglycan; fucan sulfate; physicochemical characteristics; anticoagulant activities; Alzheimer’s disease; amyloid-β; BACE1; β-secretase; glycosaminoglycan; heparan sulphate; heparin; Portunus pelagicus; nematocyst discharge process; theoretical model; polysialic acid (polySia); nematogalectin; nanomedical devices; fucoidan; therapeutic effects; bioactivity; anti-viral; apoptosis-related genes; Ehrlich ascites carcinoma; toxicity; lectin; MytiLec-1; Mytilus galloprovincialis; malignant glioma; oligo-fucoidan; differentiation induction; epigenetic modification; DNA methyltransferases; Fucus distichus subsp. evanescens; fucoidan; retinal pigment epithelium; VEGF; oxidative stress; phagocytosis; innate immunity; lectins; complement system; C1q; bivalve mollusks; tandem duplication; pattern recognition receptors